C-Reactive Protein Monitoring Identifies Urinary Tract Infections in Ambulatory Kidney Transplant Recipients

Background: Urinary tract infections (UTI) are common in kidney transplant recipients (KTR). Although risk factors for UTI are well described, predicting symptomatic UTI with positive urine cultures in the first posttransplant year is challenging. Objective: Our clinic routinely monitors serum highl...

Full description

Saved in:
Bibliographic Details
Main Authors: Emily Wang, Abdelhamid Aboghanem, Niki Dacouris, Lindita Rapi, Sami Mahmud, Weiqiu Yuan, Rosane Nisenbaum, Michelle M. Nash, G. V. Ramesh Prasad
Format: Article
Language:English
Published: SAGE Publishing 2025-05-01
Series:Canadian Journal of Kidney Health and Disease
Online Access:https://doi.org/10.1177/20543581251342428
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850149274361266176
author Emily Wang
Abdelhamid Aboghanem
Niki Dacouris
Lindita Rapi
Sami Mahmud
Weiqiu Yuan
Rosane Nisenbaum
Michelle M. Nash
G. V. Ramesh Prasad
author_facet Emily Wang
Abdelhamid Aboghanem
Niki Dacouris
Lindita Rapi
Sami Mahmud
Weiqiu Yuan
Rosane Nisenbaum
Michelle M. Nash
G. V. Ramesh Prasad
author_sort Emily Wang
collection DOAJ
description Background: Urinary tract infections (UTI) are common in kidney transplant recipients (KTR). Although risk factors for UTI are well described, predicting symptomatic UTI with positive urine cultures in the first posttransplant year is challenging. Objective: Our clinic routinely monitors serum highly sensitive C-reactive protein (CRP) as part of posttransplant care. We sought to define the role of CRP in identifying symptomatic UTI in KTR. Design: Nested case control study Setting: A large adult single-organ kidney transplant center in Toronto, Canada. Patients: We identified a nested cohort of 78 KTR who experienced a symptomatic UTI with positive urine cultures (cases) and compared them to a cohort of 78 KTR controls matched by time elapsed posttransplant. Measurements: Patient demographics, urine cultures, CRP, and kidney function during the first posttransplant year. Methods: We identified a cohort of KTR transplanted between January 1, 2016, and December 31, 2019. A positive urine culture ordered only for clinical indication in the first posttransplant year identified KTR with a UTI defined >10 5 colony forming units/mL. UTI cases were matched 1:1 to non-UTI controls transplanted immediately preceding or succeeding the UTI case. Bivariate comparisons were performed by t test, Wilcoxon 2-sample test for continuous variables, chi-square, or Fisher’s exact test as appropriate, with clinically significant variables entered into multivariable logistic regression models to determine associations. Results: Older age, female sex, and the presence of a stent were each associated with a UTI. Immediately preceding UTI, eGFR ( P = .019), serum albumin ( P < .0001), and hemoglobin ( P = .002) were lower, while serum CRP ( P < .0001) and absolute neutrophils ( P = .03) were higher in cases than controls. However, in several multivariable models, only absolute CRP ( P = .001), change in CRP ( P = .005), female sex ( P < .0001), and ureteric stent ( P = .008) consistently predicted a UTI. Each 5 mg/dL change between the 2 preceding CRP values predicted a 15% increased likelihood of UTI, while each 1 mg/dL in absolute CRP concentration was associated with a 5% risk. Limitations: Retrospective case-control design, single-center, small sample size. Hospital inpatients and patients with other infections, acute inflammatory conditions, or rejection were excluded. Urine infections may more easily be detected when patients visit the clinic frequently. Conclusions: Routine ambulatory CRP monitoring in the first year may help identify subsequent symptomatic UTI in KTR, allow for the initiation of earlier therapy, and reduce patient morbidity. What was known before? UTI in KTR are common in the first posttransplant year. Antibiotic therapy is typically not initiated until the results of urine cultures become known. What this adds: The routine use of appropriate biomarkers such as CRP as part of a posttransplant monitoring strategy may allow clinicians to order urine cultures, help identify UTI earlier, and start therapy sooner, promoting patient well-being.
format Article
id doaj-art-0f93680005894d8a97d92e64ddb5e81f
institution OA Journals
issn 2054-3581
language English
publishDate 2025-05-01
publisher SAGE Publishing
record_format Article
series Canadian Journal of Kidney Health and Disease
spelling doaj-art-0f93680005894d8a97d92e64ddb5e81f2025-08-20T02:26:58ZengSAGE PublishingCanadian Journal of Kidney Health and Disease2054-35812025-05-011210.1177/20543581251342428C-Reactive Protein Monitoring Identifies Urinary Tract Infections in Ambulatory Kidney Transplant RecipientsEmily Wang0Abdelhamid Aboghanem1Niki Dacouris2Lindita Rapi3Sami Mahmud4Weiqiu Yuan5Rosane Nisenbaum6Michelle M. Nash7G. V. Ramesh Prasad8Kidney Transplant Program, St. Michael’s Hospital, Toronto, ON, CanadaDivision of Nephrology, Department of Medicine, University of Toronto, ON, CanadaKidney Transplant Program, St. Michael’s Hospital, Toronto, ON, CanadaKidney Transplant Program, St. Michael’s Hospital, Toronto, ON, CanadaKidney Transplant Program, St. Michael’s Hospital, Toronto, ON, CanadaKidney Transplant Program, St. Michael’s Hospital, Toronto, ON, CanadaApplied Health Research Centre, Li Ka Shing Knowledge Institute, Toronto, ON, CanadaKidney Transplant Program, St. Michael’s Hospital, Toronto, ON, CanadaDivision of Nephrology, Department of Medicine, University of Toronto, ON, CanadaBackground: Urinary tract infections (UTI) are common in kidney transplant recipients (KTR). Although risk factors for UTI are well described, predicting symptomatic UTI with positive urine cultures in the first posttransplant year is challenging. Objective: Our clinic routinely monitors serum highly sensitive C-reactive protein (CRP) as part of posttransplant care. We sought to define the role of CRP in identifying symptomatic UTI in KTR. Design: Nested case control study Setting: A large adult single-organ kidney transplant center in Toronto, Canada. Patients: We identified a nested cohort of 78 KTR who experienced a symptomatic UTI with positive urine cultures (cases) and compared them to a cohort of 78 KTR controls matched by time elapsed posttransplant. Measurements: Patient demographics, urine cultures, CRP, and kidney function during the first posttransplant year. Methods: We identified a cohort of KTR transplanted between January 1, 2016, and December 31, 2019. A positive urine culture ordered only for clinical indication in the first posttransplant year identified KTR with a UTI defined >10 5 colony forming units/mL. UTI cases were matched 1:1 to non-UTI controls transplanted immediately preceding or succeeding the UTI case. Bivariate comparisons were performed by t test, Wilcoxon 2-sample test for continuous variables, chi-square, or Fisher’s exact test as appropriate, with clinically significant variables entered into multivariable logistic regression models to determine associations. Results: Older age, female sex, and the presence of a stent were each associated with a UTI. Immediately preceding UTI, eGFR ( P = .019), serum albumin ( P < .0001), and hemoglobin ( P = .002) were lower, while serum CRP ( P < .0001) and absolute neutrophils ( P = .03) were higher in cases than controls. However, in several multivariable models, only absolute CRP ( P = .001), change in CRP ( P = .005), female sex ( P < .0001), and ureteric stent ( P = .008) consistently predicted a UTI. Each 5 mg/dL change between the 2 preceding CRP values predicted a 15% increased likelihood of UTI, while each 1 mg/dL in absolute CRP concentration was associated with a 5% risk. Limitations: Retrospective case-control design, single-center, small sample size. Hospital inpatients and patients with other infections, acute inflammatory conditions, or rejection were excluded. Urine infections may more easily be detected when patients visit the clinic frequently. Conclusions: Routine ambulatory CRP monitoring in the first year may help identify subsequent symptomatic UTI in KTR, allow for the initiation of earlier therapy, and reduce patient morbidity. What was known before? UTI in KTR are common in the first posttransplant year. Antibiotic therapy is typically not initiated until the results of urine cultures become known. What this adds: The routine use of appropriate biomarkers such as CRP as part of a posttransplant monitoring strategy may allow clinicians to order urine cultures, help identify UTI earlier, and start therapy sooner, promoting patient well-being.https://doi.org/10.1177/20543581251342428
spellingShingle Emily Wang
Abdelhamid Aboghanem
Niki Dacouris
Lindita Rapi
Sami Mahmud
Weiqiu Yuan
Rosane Nisenbaum
Michelle M. Nash
G. V. Ramesh Prasad
C-Reactive Protein Monitoring Identifies Urinary Tract Infections in Ambulatory Kidney Transplant Recipients
Canadian Journal of Kidney Health and Disease
title C-Reactive Protein Monitoring Identifies Urinary Tract Infections in Ambulatory Kidney Transplant Recipients
title_full C-Reactive Protein Monitoring Identifies Urinary Tract Infections in Ambulatory Kidney Transplant Recipients
title_fullStr C-Reactive Protein Monitoring Identifies Urinary Tract Infections in Ambulatory Kidney Transplant Recipients
title_full_unstemmed C-Reactive Protein Monitoring Identifies Urinary Tract Infections in Ambulatory Kidney Transplant Recipients
title_short C-Reactive Protein Monitoring Identifies Urinary Tract Infections in Ambulatory Kidney Transplant Recipients
title_sort c reactive protein monitoring identifies urinary tract infections in ambulatory kidney transplant recipients
url https://doi.org/10.1177/20543581251342428
work_keys_str_mv AT emilywang creactiveproteinmonitoringidentifiesurinarytractinfectionsinambulatorykidneytransplantrecipients
AT abdelhamidaboghanem creactiveproteinmonitoringidentifiesurinarytractinfectionsinambulatorykidneytransplantrecipients
AT nikidacouris creactiveproteinmonitoringidentifiesurinarytractinfectionsinambulatorykidneytransplantrecipients
AT linditarapi creactiveproteinmonitoringidentifiesurinarytractinfectionsinambulatorykidneytransplantrecipients
AT samimahmud creactiveproteinmonitoringidentifiesurinarytractinfectionsinambulatorykidneytransplantrecipients
AT weiqiuyuan creactiveproteinmonitoringidentifiesurinarytractinfectionsinambulatorykidneytransplantrecipients
AT rosanenisenbaum creactiveproteinmonitoringidentifiesurinarytractinfectionsinambulatorykidneytransplantrecipients
AT michellemnash creactiveproteinmonitoringidentifiesurinarytractinfectionsinambulatorykidneytransplantrecipients
AT gvrameshprasad creactiveproteinmonitoringidentifiesurinarytractinfectionsinambulatorykidneytransplantrecipients